Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder
Primary Purpose
Overactive Bladder
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
TENS 1
TENS 2
Sponsored by
About this trial
This is an interventional treatment trial for Overactive Bladder
Eligibility Criteria
Inclusion Criteria: Being in the age range of 18-65 , Having diagnosed with OAB, Being a volunteer Exclusion Criteria: Being pregnant, presence of severe pelvic organ prolapse, malignant disease, urinary infection, neurological disease, have electronic and metal implant, loss of sensation, lumbosacral peripheral nerve lesion
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Group 1
Group 2
Arm Description
Group 1 will be applied TENS three days per week
Group 2 will be applied TENS one day per week
Outcomes
Primary Outcome Measures
Overactive bladder symptoms
Overactive bladder symptoms will be assessed with the Overactive Bladder-V8 Questionnaire
Secondary Outcome Measures
Urgency severity
Urgency severity will be assessed with Patients' Perception of Intensity of Urgency Scale
Bladder functions
Bladder functions will be assessed with voiding diary
Life quality
Life quality will be assessed with the King's Health Questionnaire
Strength of pelvic floor muscle
Strength of pelvic floor muscle will be assessed with Modified Oxford Scale
Perception of recovery
Perception of recovery will be assessed with a 4-point Likert scale
Full Information
NCT ID
NCT05672277
First Posted
January 3, 2023
Last Updated
January 3, 2023
Sponsor
Ankara Yildirim Beyazıt University
1. Study Identification
Unique Protocol Identification Number
NCT05672277
Brief Title
Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder
Official Title
Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
February 15, 2023 (Anticipated)
Primary Completion Date
June 15, 2023 (Anticipated)
Study Completion Date
February 15, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ankara Yildirim Beyazıt University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The aim of our study is a comparison of the effects of transcutaneous electrical nerve stimulation (TENS) protocols in women with overactive bladder (OAB).
Detailed Description
OAB is a condition defined by the International Continence Society as the presence of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection or other obvious pathology. TENS has positive effects on OAB. However, there are not enough studies on how often this stimulation is applied. Studies are needed on this subject.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overactive Bladder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Group 1
Arm Type
Experimental
Arm Description
Group 1 will be applied TENS three days per week
Arm Title
Group 2
Arm Type
Active Comparator
Arm Description
Group 2 will be applied TENS one day per week
Intervention Type
Other
Intervention Name(s)
TENS 1
Intervention Description
Parasacral TENS will be applied for 30 minutes 3 days a week during 6 weeks.
Intervention Type
Other
Intervention Name(s)
TENS 2
Intervention Description
Parasacral TENS will be applied for 30 minutes one day a week during 6 weeks.
Primary Outcome Measure Information:
Title
Overactive bladder symptoms
Description
Overactive bladder symptoms will be assessed with the Overactive Bladder-V8 Questionnaire
Time Frame
change from baseline at 3 weeks and 6 weeks
Secondary Outcome Measure Information:
Title
Urgency severity
Description
Urgency severity will be assessed with Patients' Perception of Intensity of Urgency Scale
Time Frame
change from baseline at 3 weeks and 6 weeks
Title
Bladder functions
Description
Bladder functions will be assessed with voiding diary
Time Frame
change from baseline at 3 weeks and 6 weeks
Title
Life quality
Description
Life quality will be assessed with the King's Health Questionnaire
Time Frame
change from baseline at 3 weeks and 6 weeks
Title
Strength of pelvic floor muscle
Description
Strength of pelvic floor muscle will be assessed with Modified Oxford Scale
Time Frame
change from baseline at 3 weeks and 6 weeks
Title
Perception of recovery
Description
Perception of recovery will be assessed with a 4-point Likert scale
Time Frame
change from baseline at 3 weeks and 6 weeks
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women with overactive bladder
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Being in the age range of 18-65 ,
Having diagnosed with OAB,
Being a volunteer
Exclusion Criteria:
Being pregnant,
presence of severe pelvic organ prolapse,
malignant disease,
urinary infection,
neurological disease,
have electronic and metal implant,
loss of sensation,
lumbosacral peripheral nerve lesion
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Seyda Toprak Celenay
Phone
+90312 906 1000
Email
sydtoprak@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Seyda Toprak Celenay
Organizational Affiliation
Ankara Yildirim Beyazıt University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder
We'll reach out to this number within 24 hrs